IDEXX LABORATORIES INC /DE Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal
IDEXX LABORATORIES INC /DE (IDXX) reported Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal of -$3.50 million for the 12-month period ending 2012-12-31, per its 10-K filed 2015-02-17.
Discontinued › Income Statement › Other Income
us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal · last filed 2015-02-17
- IDEXX LABORATORIES INC /DE disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2012 was -$3.50M.
- IDEXX LABORATORIES INC /DE disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2011 was -$3.00M.
- IDEXX LABORATORIES INC /DE disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2010 was -$3.00M, a 250.00% decline from fiscal 2009.
- IDEXX LABORATORIES INC /DE disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2009 was $2.00M.
| Period end | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 12 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 12 month as first filed |
|---|---|---|
| 2012-12-31 | -$3.50M 10-K · filed 2015-02-17 | |
| 2011-12-31 | -$3.00M 10-K · filed 2014-02-18 | $3.00M 10-K · filed 2012-02-17 |
| 2010-12-31 | -$3.00M 10-K · filed 2013-02-19 | $3.00M 10-K · filed 2011-02-22 |
| 2009-12-31 | $2.00M 10-K · filed 2012-02-17 | |
| 2008-12-31 | -$1.48M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |